Canaccord Genuity Group Initiates Coverage on Billiontoone (NASDAQ:BLLN)

Canaccord Genuity Group initiated coverage on shares of Billiontoone (NASDAQ:BLLN) in a report released on Wednesday, MarketBeat.com reports. The brokerage set a “buy” rating and a $120.00 price target on the stock. Canaccord Genuity Group’s price objective suggests a potential upside of 24.80% from the stock’s current price.

Other equities research analysts have also recently issued research reports about the stock. BTIG Research lowered their target price on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a report on Thursday, August 6th. Weiss Ratings upgraded shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, June 23rd. JPMorgan Chase & Co. lowered their target price on Billiontoone from $145.00 to $130.00 and set an “overweight” rating for the company in a research note on Thursday, August 6th. Guggenheim started coverage on Billiontoone in a research report on Monday, June 29th. They set a “buy” rating and a $125.00 price target on the stock. Finally, Wall Street Zen lowered Billiontoone from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Seven analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $125.88.

Billiontoone Trading Up 4.1%

Shares of NASDAQ BLLN opened at $96.15 on Wednesday. The firm has a market capitalization of $4.54 billion and a P/E ratio of 137.36. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31. The company’s 50 day simple moving average is $114.43 and its 200 day simple moving average is $95.38. Billiontoone has a fifty-two week low of $61.96 and a fifty-two week high of $150.44.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.15. The business had revenue of $109.45 million for the quarter. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%. On average, analysts predict that Billiontoone will post 0.83 EPS for the current year.

Insider Activity at Billiontoone

In related news, insider Shan Riku Sakakibara sold 4,000 shares of the firm’s stock in a transaction that occurred on Friday, July 31st. The shares were sold at an average price of $140.21, for a total value of $560,840.00. Following the sale, the insider owned 200,000 shares in the company, valued at approximately $28,042,000. This trade represents a 1.96% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 32,500 shares of the business’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $136.95, for a total value of $4,450,875.00. Following the sale, the chief executive officer owned 20,000 shares of the company’s stock, valued at approximately $2,739,000. This represents a 61.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 224,883 shares of company stock worth $25,698,744. 50.22% of the stock is owned by insiders.

Hedge Funds Weigh In On Billiontoone

Large investors have recently made changes to their positions in the business. Rossby Financial LCC bought a new stake in Billiontoone in the 4th quarter valued at $25,000. Wells Fargo & Company MN purchased a new stake in shares of Billiontoone during the 4th quarter worth approximately $76,000. Smartleaf Asset Management LLC bought a new stake in Billiontoone in the fourth quarter worth $80,000. Nano Cap New Millennium Growth Fund L P bought a new position in Billiontoone during the fourth quarter valued at $82,000. Finally, Caitong International Asset Management Co. Ltd purchased a new position in shares of Billiontoone in the 4th quarter worth $230,000.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.